These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31547456)

  • 1. Norovirus Capsid Protein-Derived Nanoparticles and Polymers as Versatile Platforms for Antigen Presentation and Vaccine Development.
    Tan M; Jiang X
    Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31547456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineered Norovirus S
    Xia M; Huang P; Sun C; Han L; Vago FS; Li K; Zhong W; Jiang W; Klassen JS; Jiang X; Tan M
    ACS Nano; 2018 Nov; 12(11):10665-10682. PubMed ID: 30234973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.
    Tan M; Jiang X
    Nanomedicine (Lond); 2012 Jun; 7(6):889-97. PubMed ID: 22734641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norovirus P particle, a novel platform for vaccine development and antibody production.
    Tan M; Huang P; Xia M; Fang PA; Zhong W; McNeal M; Wei C; Jiang W; Jiang X
    J Virol; 2011 Jan; 85(2):753-64. PubMed ID: 21068235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branched-linear and agglomerate protein polymers as vaccine platforms.
    Wang L; Xia M; Huang P; Fang H; Cao D; Meng XJ; McNeal M; Jiang X; Tan M
    Biomaterials; 2014 Sep; 35(29):8427-38. PubMed ID: 24985736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of a novel method without sequence modification for developing NoV P particle-based chimeric vaccines.
    Li Y; Fu L; Hu Y; Jin H; Zheng Y; Yin Y; Wu H; Yu X; Kong W
    Protein Expr Purif; 2016 May; 121():73-80. PubMed ID: 26773744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus.
    Xia M; Wei C; Wang L; Cao D; Meng XJ; Jiang X; Tan M
    Vaccine; 2016 Feb; 34(7):905-13. PubMed ID: 26778421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advancements in combination subunit vaccine development.
    Tan M; Jiang X
    Hum Vaccin Immunother; 2017 Jan; 13(1):180-185. PubMed ID: 27649319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subviral particle as vaccine and vaccine platform.
    Tan M; Jiang X
    Curr Opin Virol; 2014 Jun; 6():24-33. PubMed ID: 24662314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabbit hemorrhagic disease virus capsid, a versatile platform for foreign B-cell epitope display inducing protective humoral immune responses.
    Moreno N; Mena I; Angulo I; Gómez Y; Crisci E; Montoya M; Castón JR; Blanco E; Bárcena J
    Sci Rep; 2016 Aug; 6():31844. PubMed ID: 27549017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.
    Ghosh S; Malik YS; Kobayashi N
    Curr Drug Metab; 2018; 19(3):170-191. PubMed ID: 28901254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors.
    Tan M; Jiang X
    J Virol; 2005 Nov; 79(22):14017-30. PubMed ID: 16254337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norovirus vaccines under development.
    Lucero Y; Vidal R; O'Ryan G M
    Vaccine; 2018 Aug; 36(36):5435-5441. PubMed ID: 28668568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a yeast-based VLP platform for antigen presentation.
    Wetzel D; Rolf T; Suckow M; Kranz A; Barbian A; Chan JA; Leitsch J; Weniger M; Jenzelewski V; Kouskousis B; Palmer C; Beeson JG; Schembecker G; Merz J; Piontek M
    Microb Cell Fact; 2018 Feb; 17(1):17. PubMed ID: 29402276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization and antigen presentation by mouse dendritic cells of rotavirus VP6 preparations differing in nanostructure.
    Tamminen K; Heinimäki S; Gröhn S; Blazevic V
    Mol Immunol; 2020 Jul; 123():26-31. PubMed ID: 32388275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus.
    Xia M; Wei C; Wang L; Cao D; Meng XJ; Jiang X; Tan M
    Sci Rep; 2016 May; 6():25735. PubMed ID: 27194006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of NoV P particle-based chimeric protein vaccines developed from two different expression systems.
    Fu L; Jin H; Yu Y; Yu B; Zhang H; Wu J; Yin Y; Yu X; Wu H; Kong W
    Protein Expr Purif; 2017 Feb; 130():28-34. PubMed ID: 27693623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norovirus P particle: an excellent vaccine platform for antibody production against Alzheimer's disease.
    Fu L; Li Y; Hu Y; Yu B; Zhang H; Wu J; Wu H; Yu X; Kong W
    Immunol Lett; 2015 Nov; 168(1):22-30. PubMed ID: 26349054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice.
    Li Z; Cui K; Huang K; Liu F; Shi D; Liu Q
    Protein Pept Lett; 2019; 26(12):904-909. PubMed ID: 31429685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.